IRISanRaf

STOCCHI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.768
AS - Asia 3.903
EU - Europa 659
Continente sconosciuto - Info sul continente non disponibili 110
SA - Sud America 103
OC - Oceania 16
AF - Africa 10
Totale 10.569
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.980
TR - Turchia 2.036
SG - Singapore 955
CA - Canada 773
CN - Cina 766
IT - Italia 216
DE - Germania 110
EU - Europa 110
BR - Brasile 95
IE - Irlanda 76
UA - Ucraina 51
GB - Regno Unito 41
IN - India 32
HK - Hong Kong 29
RU - Federazione Russa 26
FI - Finlandia 24
JP - Giappone 23
FR - Francia 18
NL - Olanda 15
KR - Corea 14
PL - Polonia 14
BD - Bangladesh 11
MX - Messico 11
SE - Svezia 11
AU - Australia 10
GR - Grecia 10
DK - Danimarca 9
ES - Italia 9
RO - Romania 8
IL - Israele 7
NZ - Nuova Zelanda 6
SI - Slovenia 6
VN - Vietnam 6
LT - Lituania 5
ZA - Sudafrica 5
TH - Thailandia 4
AR - Argentina 3
CH - Svizzera 3
KE - Kenya 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
EG - Egitto 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LU - Lussemburgo 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.569
Salva come PNG Salva come JPEG
Città #
Kocaeli 1.743
San Mateo 1.283
Toronto 752
Chandler 392
Houston 382
Wilmington 373
Santa Clara 362
Singapore 291
Lawrence 249
Princeton 249
Ashburn 160
Beijing 155
Fairfield 151
Woodbridge 88
Los Angeles 87
Seattle 78
Shanghai 69
Guangzhou 61
Cambridge 33
Shenzhen 33
Rome 31
Dublin 29
Dallas 28
Hong Kong 27
Milan 23
Munich 22
Wuhan 19
Helsinki 18
Jiaxing 18
Rui'an 18
Assago 16
Boardman 15
Brooklyn 15
São Paulo 15
Boston 14
New York 13
The Dalles 12
Tokyo 12
Warsaw 11
Xi'an 11
Quanzhou 10
Redwood City 9
Wuxi 9
Xuzhou 9
Pune 8
Washington 8
West Jordan 8
Andover 7
Chennai 7
Frankfurt am Main 7
Mexico City 7
Nanjing 7
Redmond 7
Solagna 7
St Petersburg 7
Chicago 6
Kyiv 6
Montreal 6
San Francisco 6
Stockholm 6
Timisoara 6
Belo Horizonte 5
Dongyang 5
Florence 5
Melbourne 5
Moscow 5
Rockville 5
Auckland 4
Austin 4
Bologna 4
Chiang Mai 4
Clifton 4
Denver 4
Incheon 4
Johannesburg 4
Ljubljana 4
London 4
Minoh 4
Montegabbione 4
Nocera Inferiore 4
Phoenix 4
Qingdao 4
Seoul 4
Sydney 4
Taizhou 4
Yeonsu-gu 4
Amsterdam 3
Aparecida de Goiania 3
Camarillo 3
Chengdu 3
Cisterna di Latina 3
Dhaka 3
Gatchina 3
Genova 3
Giresun 3
Haining 3
Jinan 3
Maceió 3
Manchester 3
Mumbai 3
Totale 7.659
Salva come PNG Salva come JPEG
Nome #
Morbo di Parkinson: strategie terapeutiche e qualità della vita del malato 96
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 87
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease 76
L’alimentazione del paziente parkinsoniano 67
Apomorphine and lisuride infusion. A comparative chronic study 63
A pharmacological study of dopaminergic receptors in planaria 61
Gastrointestinal dysfunction in Parkinson's disease 59
Side-effects of subcutaneous apomorphine in Parkinson's disease 58
Modification of respiratory function parameters in patients with severe Parkinson's disease 58
Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study 58
Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test 56
Adherence to antiparkinson medication in a multicenter European study 56
One year treatment with lisuride delivery pump in Parkinson's disease 56
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease 55
Neuroprotection in Parkinson's disease: clinical trials 55
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 55
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score Epub 2016 53
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor 53
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia 53
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives 52
A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm 51
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease 51
Case Study 10 50
Managing the critical problems of advanced Parkinson's disease 50
Transient atrial fibrillation after subcutaneous apomorphine bolus 50
Transient left bundle branch block following intravenous lisuride bolus 49
Levodopa: A new look at an old friend 49
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 49
The coefficient of friction in Parkinson's disease gait 49
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations 48
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease 48
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease 48
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders 48
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm 48
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 48
Clinical Experiences With Levodopa Methylester (Melevodopa) in Patients With Parkinson Disease Experiencing Motor Fluctuations: An Open-Label Observational Study 48
Jejunal delivery of levodopa methyl ester 47
Antagonist effect of terguride in Parkinson's disease 47
Constipation in Parkinson's Disease 47
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics 47
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 47
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes 47
Comparison between L-dopa and lisuride intravenous infusions: a clinical study 47
Use of Apomorphine in Parkinson’s Disease 47
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results 47
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 47
Management of gastrointestinal alterations in Parkinson's disease 46
Multicenter trial of L-Deprenyl in Parkinson disease 46
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients 46
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease 46
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease 46
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need 46
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease 46
Instrumental diagnosis of multiple system atrophy 45
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 45
Combination of two different dopamine agonists in the management of Parkinson's disease 45
On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation 45
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease 45
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder 45
Parkinson's Disease: Non-motor and non-dopaminergic Features 44
Effects of terguride in patients with Huntington's disease 44
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease 44
trategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias 44
Novel parkin mutations detected in patients with early-onset Parkinson's disease 44
GIGYF2 mutations are not frequent cause of familiar Parkinson’s disease 44
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 44
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment 44
Continuous dopamine-receptor stimulation in advanced Parkinson's disease 44
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data 44
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies 43
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 43
Dual dopamine agonist treatment in Parkinson's disease 43
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease 43
Motor fluctuations in levodopa treatment: clinical pharmacology 43
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease 43
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 43
Optimising levodopa therapy for the management of Parkinson's disease 43
Emergencies in Parkinson's disease 42
Transient cardiac arrest during continuous intravenous infusion of apomorphine 42
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease 42
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection 42
Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy 42
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 42
Prevention and treatment of motor fluctuations 42
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease 42
Alterations of thermoregulation in Parkinson's disease 42
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 42
Farmaci Antiparkinsoniani 42
Gastrointestinal, urological, and sleep problems in parkinson's disease 41
Malattie Extrapiramidali: aspetti clinici e terapeutici nelle sindromi parkinsoniane 41
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study 41
Validation of the freezing of gait questionnaire in patients with Parkinson's disease 41
An appraisal of the problem of dementia in Parkinson's disease 41
Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report 41
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease 41
Wearing-off scales in Parkinson's disease: Critique and recommendations 41
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial 41
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease 41
Long-term effects of automated mechanical peripheral stimulation on gait patterns of patients with Parkinson's disease 41
A pharmacological study of cocaine activity in planaria 41
Totale 4.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.683 146 134 36 8 44 170 83 39 63 47 1.746 167
2021/20222.486 11 761 758 9 6 1 209 281 18 351 6 75
2022/20231.298 561 35 12 118 83 31 2 86 93 113 160 4
2023/20241.031 4 19 81 243 50 45 15 60 13 87 26 388
2024/20252.630 127 591 159 126 95 387 118 185 389 24 90 339
2025/202683 83 0 0 0 0 0 0 0 0 0 0 0
Totale 10.977